Are you Dr. Cannistra?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 77 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Brookline Ave
Beth Israel Deaconess Medical Center
Boston, MA 02215Phone+1 617-667-4283- Is this information wrong?
Summary
- Dr. Stephen Cannistra, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is a Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984
Johns Hopkins UniversityResidency, Internal Medicine, 1979 - 1981
The Warren Alpert Medical School of Brown UniversityClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2021
Clinical Trials
- Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer Start of enrollment: 1999 Jul 01
- Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors Start of enrollment: 1999 Jul 01
- Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2002 May 01
Publications & Presentations
PubMed
- 14 citationsImmune Checkpoint Inhibitors in Ovarian Cancer: Can We Bridge the Gap Between IMagynation and Reality?Panagiotis A. Konstantinopoulos, Stephen A. Cannistra> ;Journal of Clinical Oncology. 2021 Apr 23
- 1 citationsThe End of a Fantastic Voyage.Stephen A. Cannistra> ;Journal of Clinical Oncology. 2021 Apr 20
- 29 citationsChallenges Faced by Medical Journals During the COVID-19 Pandemic.Stephen A. Cannistra, Bruce G. Haffty, Karla V. Ballman> ;Journal of Clinical Oncology. 2020 Apr 8
- Join now to see all
Press Mentions
Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian CancerOctober 28th, 2019
Grant Support
- Cp-547,632 In Subjects With CancerNational Center For Research Resources2005
- Adhesion Protein And Ovarian Cancer ImplantationNational Cancer Institute1993–1996
- Role Of IA Antigens In Regulation Of Human MyelopoiesisNational Cancer Institute1985–1986
Professional Memberships
- Member
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
